AAAAAA
Results:
1-14
|
Results: 14
Authors:
Segura, M
Ortuno, J
Farre, M
McLure, JA
Pujadas, M
Pizarro, N
Llebaria, A
Joglar, J
Roset, PN
Segura, J
de la Torre, R
Citation: M. Segura et al., 3,4-dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans, CHEM RES T, 14(9), 2001, pp. 1203-1208
Authors:
Farre, M
Hernandez-Lopez, C
Peiro, AM
Roset, PN
Citation: M. Farre et al., Computer resources as a tool for rational therapeutics, METH FIND E, 23(6), 2001, pp. 283-284
Authors:
Roset, PN
Farre, M
de la Torre, R
Mas, M
Menoyo, E
Hernandez, C
Cami, J
Citation: Pn. Roset et al., Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males, DRUG AL DEP, 64(3), 2001, pp. 285-298
Authors:
Pacifici, R
Farre, M
Pichini, S
Ortuno, J
Roset, PN
Zuccaro, P
Segura, J
de la Torre, R
Citation: R. Pacifici et al., Sweat testing of MDMA with the Drugwipe (R) analytical device: A controlled study with two volunteers, J ANAL TOX, 25(2), 2001, pp. 144-146
Authors:
Pacifici, R
Zuccaro, P
Farre, M
Pichini, S
Di Carlo, S
Roset, PN
Ortuno, J
Pujadas, M
Bacosi, A
Menoyo, E
Segura, J
de la Torre, R
Citation: R. Pacifici et al., Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans, LIFE SCI, 69(24), 2001, pp. 2931-2941
Authors:
Pacifici, R
Zuccaro, P
Lopez, CH
Pichini, S
Di Carlo, S
Farre, M
Roset, PN
Ortuno, J
Segura, J
De la Torre, R
Citation: R. Pacifici et al., Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans, J PHARM EXP, 296(1), 2001, pp. 207-215
Authors:
Navarro, M
Pichini, S
Farre, M
Ortuno, J
Roset, PN
Segura, J
de la Torre, R
Citation: M. Navarro et al., Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: Correlation with plasma drug concentrations and effectof salivary pH, CLIN CHEM, 47(10), 2001, pp. 1788-1795
Authors:
de la Torre, R
Farre, M
Ortuno, J
Mas, M
Brenneisen, R
Roset, PN
Segura, J
Cami, J
Citation: R. De La Torre et al., Non-linear pharmacokinetics of MDMA ('ecstasy') in humans, BR J CL PH, 49(2), 2000, pp. 104-109
Authors:
Cami, J
Farre, M
Mas, M
Roset, PN
Poudevida, S
Mas, A
San, L
de la Torre, R
Citation: J. Cami et al., Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): Psychomotor performance and subjective effects, J CL PSYCH, 20(4), 2000, pp. 455-466
Authors:
Banos, JE
Roset, PN
Farre, M
Citation: Je. Banos et al., Vitamins or amphetamines?, MED CLIN, 115(19), 2000, pp. 759-759
Authors:
Arasteh, K
Poudevida, S
Farre, M
Roset, PN
Cami, J
Citation: K. Arasteh et al., Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants,and opioids, DRUG AL DEP, 55(1-2), 1999, pp. 117-125
Authors:
Pacifici, R
Zuccaro, P
Farre, M
Pichini, S
Di Carlo, S
Roset, PN
Ortuno, J
Segura, J
de la Torre, R
Citation: R. Pacifici et al., Immunomodulating properties of MDMA alone and in combination with alcohol:A pilot study, LIFE SCI, 65(26), 1999, pp. PL309-PL316
Authors:
Mas, M
Farre, M
De la Torre, R
Roset, PN
Ortuno, J
Segura, J
Cami, J
Citation: M. Mas et al., Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans, J PHARM EXP, 290(1), 1999, pp. 136-145
Authors:
Farre, M
Teran, MT
Roset, PN
Mas, M
Torrens, M
Cami, J
Citation: M. Farre et al., Abuse liability of flunitrazepam among methadone maintained patients, PSYCHOPHAR, 140(4), 1998, pp. 486-495
Risultati:
1-14
|